The present study showed that the differences in the plasma levels of IL-17 and IL-6 among the subjects with lesions, HNSCC or HNSCC subjects that received 1,25(OH)2D3 treatment are analogous to the differences seen in the oral tissues from these patient groups. This evidence concerns the gene IL6 and head and neck squamous cell carcinoma.